FDA panel will hold a public hearing on orphan-drug research

06/28/2010 | Reuters

An FDA committee will hold a two-day public hearing this week to discuss strategies that would encourage drugmakers to develop treatments for rare diseases. The meeting comes after the FDA released a list of approved medicines that could be used for orphan-drug research.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL